Patient Support Programmes aim to positively impact the health outcomes and quality of life of people living with illness by promoting adherence to therapy and its effectiveness and safety, as well as generating evidence on the use of medicines in a real-life context and health gains1-4.To this end, it is proposed to disseminate the participation of pharmacies in monitoring and support programmes for people living with illness, which aim to achieve defined objectives of health gains with the use of technologies, directed at target populations and which can be paid for by the NHS, insurers, the pharmaceutical industry, as well as other agents, generating evidence through the collection of data that can enhance the health journey of its recipients.
1. Deloitte. Patient support programmes: Driving competitive advantage and commercial success. 2020. https://www2.deloitte.com/content/dam/Deloitte/uk/Documents/life-sciences-health-care/deloitte-uk-patient-support-programmes.pdf. 2. Ganguli A, Clewell J, Shillington AC. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient Prefer Adherence 2016;10:711–25. doi:10.2147/PPA.S101175. 3. Jokinen J, Bertin D, Donzanti B, et al. Industry Assessment of the Contribution of Patient Support Programs, Market Research Programs, and Social Media to Patient Safety. Ther Innov Regul Sci 2019;53:736–45. doi:10.1177/2168479019877384. 4. Zhang H, Huang T, Yan T. A quantitative analysis of risk-sharing agreements with patient support programs for improving medication adherence. Health Care Manag Sci 2022;25:253–74. doi:10.1007/S10729-021-09587-9.